(CIDRAP News) Some of the world's leading experts on biological weapons and public health will meet in Geneva, Switzerland, Oct 21 and 22 for an international conference on the threat of a bioterrorist attack involving smallpox.
(CIDRAP News) – The outbreak of H5N1 avian influenza in Asia gives the world its first opportunity to prepare a vaccine in advance for a potential pandemic strain of flu, the World Health Organization (WHO) said today as it convened a meeting of vaccine companies and health officials to consider the challenge.
(CIDRAP News) The World Health Organization's top influenza expert warned at the end of a 2-day international meeting today that governments need to fund the development of vaccines to combat a feared flu pandemic that could kill millions of people, according to news services.
(CIDRAP News) The United States proposed today that a small group of experts be appointed immediately to plan a fast response in case an influenza pandemic erupts, as an international conference on avian and pandemic flu continued in Geneva.
(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.
(CIDRAP News) The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
The World Health Organization's (WHO's) global count of confirmed swine flu cases stands at 257 cases in 11 countries today. The United States has 109 cases and 1 death; Mexico has 97 cases and 7 deaths. [WHO update 6]
(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.